146 related articles for article (PubMed ID: 27593339)
1. Discovery of Novel Antischistosomal Agents by Molecular Modeling Approaches.
Mafud AC; Ferreira LG; Mascarenhas YP; Andricopulo AD; de Moraes J
Trends Parasitol; 2016 Nov; 32(11):874-886. PubMed ID: 27593339
[TBL] [Abstract][Full Text] [Related]
2. Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence.
Moreira-Filho JT; Silva AC; Dantas RF; Gomes BF; Souza Neto LR; Brandao-Neto J; Owens RJ; Furnham N; Neves BJ; Silva-Junior FP; Andrade CH
Front Immunol; 2021; 12():642383. PubMed ID: 34135888
[TBL] [Abstract][Full Text] [Related]
3. Toward organometallic antischistosomal drug candidates.
Hess J; Keiser J; Gasser G
Future Med Chem; 2015; 7(6):821-30. PubMed ID: 25996072
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for Fighting Schistosomiasis: Past, Present and Future.
Mäder P; Rennar GA; Ventura AMP; Grevelding CG; Schlitzer M
ChemMedChem; 2018 Nov; 13(22):2374-2389. PubMed ID: 30212614
[TBL] [Abstract][Full Text] [Related]
5. Schistosomiasis control: praziquantel forever?
Cioli D; Pica-Mattoccia L; Basso A; Guidi A
Mol Biochem Parasitol; 2014 Jun; 195(1):23-9. PubMed ID: 24955523
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
Liu LX; Li-Li J; Qiong C; Xiao-Lin F
Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
[TBL] [Abstract][Full Text] [Related]
7. Discovery of New Anti-Schistosomal Hits by Integration of QSAR-Based Virtual Screening and High Content Screening.
Neves BJ; Dantas RF; Senger MR; Melo-Filho CC; Valente WC; de Almeida AC; Rezende-Neto JM; Lima EF; Paveley R; Furnham N; Muratov E; Kamentsky L; Carpenter AE; Braga RC; Silva-Junior FP; Andrade CH
J Med Chem; 2016 Aug; 59(15):7075-88. PubMed ID: 27396732
[TBL] [Abstract][Full Text] [Related]
8. Structure-Based Study of Natural Products with Anti-Schistosoma Activity.
Akachukwu I; Olubiyi OO; Kosisochukwu A; John MC; Justina NN
Curr Comput Aided Drug Des; 2017; 13(2):91-100. PubMed ID: 28103771
[TBL] [Abstract][Full Text] [Related]
9. Target-based molecular modeling strategies for schistosomiasis drug discovery.
Ferreira LG; Oliva G; Andricopulo AD
Future Med Chem; 2015; 7(6):753-64. PubMed ID: 25996068
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of praziquantel and endoperoxide conjugates as antischistosomal agents.
Yang JJ; Boissier J; Chen JL; Yao H; Yang S; Rognon A; Qiao C
Future Med Chem; 2015; 7(6):713-25. PubMed ID: 25996065
[TBL] [Abstract][Full Text] [Related]
11. Natural products with antischistosomal activity.
de Moraes J
Future Med Chem; 2015; 7(6):801-20. PubMed ID: 25996071
[TBL] [Abstract][Full Text] [Related]
12. Will new antischistosomal drugs finally emerge?
Cioli D; Valle C; Angelucci F; Miele AE
Trends Parasitol; 2008 Sep; 24(9):379-82. PubMed ID: 18675590
[TBL] [Abstract][Full Text] [Related]
13. Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.
Vale N; Gouveia MJ; Rinaldi G; Brindley PJ; Gärtner F; Correia da Costa JM
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264841
[TBL] [Abstract][Full Text] [Related]
14. Could we expect new praziquantel derivatives? A meta pharmacometrics/pharmacoinformatics analysis of all antischistosomal praziquantel derivatives found in the literature.
da Silva VBR; Boucherle B; El-Methni J; Hoffmann B; da Silva AL; Fortune A; de Lima MDCA; Thomas A
SAR QSAR Environ Res; 2019 Jun; 30(6):383-401. PubMed ID: 31144535
[TBL] [Abstract][Full Text] [Related]
15. Modern approaches to accelerate discovery of new antischistosomal drugs.
Neves BJ; Muratov E; Machado RB; Andrade CH; Cravo PV
Expert Opin Drug Discov; 2016 Jun; 11(6):557-67. PubMed ID: 27073973
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antischistosomal activity of linker- and thiophene-modified biaryl alkyl carboxylic acid derivatives.
Peter Ventura AM; Haeberlein S; Konopka L; Obermann W; Grünweller A; Grevelding CG; Schlitzer M
Arch Pharm (Weinheim); 2021 Dec; 354(12):e2100259. PubMed ID: 34523746
[TBL] [Abstract][Full Text] [Related]
17. Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use.
Abdul-Ghani RA; Loutfy N; Hassan A
Parasitol Res; 2009 Oct; 105(4):899-906. PubMed ID: 19588166
[TBL] [Abstract][Full Text] [Related]
18. A multi-dimensional, time-lapse, high content screening platform applied to schistosomiasis drug discovery.
Chen S; Suzuki BM; Dohrmann J; Singh R; Arkin MR; Caffrey CR
Commun Biol; 2020 Dec; 3(1):747. PubMed ID: 33349640
[TBL] [Abstract][Full Text] [Related]
19. Current drug strategies for the treatment and control of schistosomiasis.
Villamizar-Monsalve MA; López-Abán J; Vicente B; Peláez R; Muro A
Expert Opin Pharmacother; 2024 Mar; 25(4):409-420. PubMed ID: 38511392
[TBL] [Abstract][Full Text] [Related]
20. Impedance-Based Microfluidic Assay for Automated Antischistosomal Drug Screening.
Chawla K; Modena MM; Ravaynia PS; Lombardo FC; Leonhardt M; Panic G; Bürgel SC; Keiser J; Hierlemann A
ACS Sens; 2018 Dec; 3(12):2613-2620. PubMed ID: 30426744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
